Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Shares Sold by Alliancebernstein L.P.

Alliancebernstein L.P. lessened its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 4.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,820 shares of the company’s stock after selling 3,350 shares during the quarter. Alliancebernstein L.P.’s holdings in Aveanna Healthcare were worth $310,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. State Street Corp grew its stake in shares of Aveanna Healthcare by 0.9% during the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company’s stock worth $5,408,000 after purchasing an additional 9,446 shares during the period. Jane Street Group LLC increased its holdings in Aveanna Healthcare by 127.4% in the third quarter. Jane Street Group LLC now owns 118,803 shares of the company’s stock valued at $618,000 after buying an additional 66,561 shares in the last quarter. Barclays PLC lifted its position in shares of Aveanna Healthcare by 80.1% during the 3rd quarter. Barclays PLC now owns 122,689 shares of the company’s stock valued at $637,000 after acquiring an additional 54,557 shares during the period. Geode Capital Management LLC boosted its stake in shares of Aveanna Healthcare by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock worth $7,287,000 after acquiring an additional 63,190 shares in the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of Aveanna Healthcare in the 3rd quarter worth approximately $99,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have commented on AVAH. Truist Financial decreased their target price on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, April 11th. UBS Group raised their target price on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a report on Friday, March 14th.

Insiders Place Their Bets

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $5.63, for a total value of $31,415.40. Following the sale, the insider now directly owns 1,451,598 shares of the company’s stock, valued at approximately $8,172,496.74. This trade represents a 0.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last three months, insiders sold 67,412 shares of company stock valued at $372,142. Company insiders own 7.80% of the company’s stock.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock opened at $4.22 on Tuesday. The firm’s 50-day moving average is $4.76 and its two-hundred day moving average is $4.91. The stock has a market capitalization of $823.30 million, a P/E ratio of -12.41 and a beta of 1.99. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.15 and a 12-month high of $6.19.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.